Agility Robotics, a leading humanoid robotics and Physical AI company, today announced that the Comp

Churchill Capital Corp XI (NASDAQ:CCXI) shares are rising Wednesday morning as investors search for

Churchill Capital Corp XI shares are rising Wednesday morning as investors seek liquid, public proxi

Churchill Capital Corp XI rise nearly 5% after securing new working capital as it advances its Agili

Agility Robotics, a leading humanoid robotics and Physical AI company, today announced the appointme

Experienced public company finance executive joins Agility as company expands commercial momentum an

Bay Area facility will advance the AI technologies that enable its humanoid robot, Digit, to learn n

Agility Robotics, Inc. (“Agility” or the “Company”) creator of the general-purpose humanoid

SALEM, Ore. & NEW YORK--(BUSINESS WIRE)--Agility Robotics, Inc. (“Agility” or the “Company”) creator

Churchill Capital Corp XI shares are in focus Monday as its planned merger with Agility Robotics con

US stocks fall, Nasdaq down 200 points. Progress Software (NASDAQ: PRGS) shares rise 11.7% after bea

Churchill Capital Corp XI (NASDAQ:CCXI) shares are up during Wednesday's premarket session, trading

Churchill Capital Corp XI shares are up in Wednesday's premarket as traders weigh the SEC filing

Churchill Capital Corp XI is edging lower in Tuesday's premarket, as traders weigh its definitiv

Dow Jones gains 350 points, Iridium acquired by Rocket Lab for $8B, big stocks recording gains: Quid

Shares of Churchill Capital Corp XI are trading higher Monday after announcing a $2.5 billion busine

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ

A humanoid robotics company and Tesla rival is going public. Here's what's next for the comp

Agility Robotics plans to go public via a SPAC at a $2.5 billion valuation. Agility has deployed Dig

A maker of humanlike robots that carry totes around warehouses is going public on Wall Street in a t

U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares j

Operating today in commercial environments with leading enterprises including Schaeffler, GXO, Toyot

SALEM, Ore. & NEW YORK--(BUSINESS WIRE)--Agility Robotics, Inc. (“Agility” or the “Company”), a lead

Leifras Co Ltd (NASDAQ: LFS) rose in pre-market trading after acquiring SWIFT JAPAN for JPY454.6 mil

https://www.wsj.com/finance/agility-maker-of-humanlike-robots-to-go-public-in-2-5-billion-spac-deal-

Dow Jones falls 250 points as UnitedHealth Group rises on Medicare reimbursement boost, other stocks

According to data from Benzinga Pro, during Q2, ChemoCentryx's (NASDAQ:CCXI) reported sales tota

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Charles Schwab Corporation (NYSE:

Stifel analyst Dae Gon Ha downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Hold and lowers the p

  ChemoCentryx (NASDAQ:CCXI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 P

ChemoCentryx, Inc., (NASDAQ:CCXI), today announced the cancellation of its second quarter 2022 finan

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

  ChemoCentryx (NASDAQ:CCXI) is set to give its latest quarterly earnings report on Tuesday, 2022-0

Over the past 3 months, 4 analysts have published their opinion on ChemoCentryx (NASDAQ:CCXI) stock.

Upgrades

SVB Leerink analyst Joseph Schwartz downgrades ChemoCentryx (NASDAQ:CCXI) from Outperform to Mark

ChemoCentryx (NASDAQ:CCXI) has observed the following analyst ratings within the last quarter:

HC Wainwright & Co. analyst Edward White downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Ne

Canaccord Genuity analyst Edward Nash downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Hold and

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after th

Raymond James analyst Steven Seedhouse downgrades ChemoCentryx (NASDAQ:CCXI) from Strong Buy to M

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is th

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 75 points on

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after g

Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking ann

U.S. stocks pared some losses midway through trading, with the Nasdaq Composite turning higher on Th

U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Thursday.

Canaccord Genuity analyst Edward Nash assumes ChemoCentryx (NASDAQ:CCXI) with a Buy rating and an